ChEBI
neuroprotective agent
- Term ID
-
CHEBI:63726
- Synonyms
-
- neuroprotectant
- neuroprotectants
- neuroprotective agents
- Definition
-
Any compound that can be used for the treatment of neurodegenerative disorders.
- References
-
- Ontology
-
ChEBI
(
EBI
)
Relationships
- is a type of
-
- inverse has_role
-
(+)-schisandrin B
(+)-sesamin
(+)-SKF-10,047
(-)-epigallocatechin 3-gallate
(-)-N(6)-(2-phenylisopropyl)adenosine
(3R,4S,1'R)-3-(1'-hydroxyethyl)-4-methyldihydrofuran-2(3H)-one
(25R)-cholest-5-ene-3beta,26-diol
(E,E)-germacrone
(R,R)-5,11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol
1-hydroxy-5-phenyl-3-pentanone
1-isothiocyanato-6-(methylsulfanyl)hexane
3-hydroxymethyl-4-methyl-furan-2(5H)-one
3-iodothyronamine
4-amino-TEMPO
4-hydroxy-TEMPO
5,5-dimethyl-1-pyrroline N-oxide
5-methoxytryptamine
6alpha-methylprednisolone
7-chlorokynurenic acid
7-ketocholesterol
7beta-hydroxyepiandrosterone
Ac-Tyr-Val-Ala-Asp-chloromethylketone
acteoside
ajugaciliatin B
ajugamarin A1 chlorohydrin
ajugamarin A2 chlorohydrin
akebia saponin D
albiflorin
alliin
alliin zwitterion
alpha-tocotrienol
amburoside A
AMN082 dihydrochloride
anacardic acid
ananolignan F
ananolignan L
apelin-12
apelin-13
arachidonyl-2'-chloroethylamide
argon(0)
aspernigrin B
aspirin-triggered protectin D1
astragaloside IV
astressin
auraptene
baicalin
BAY 73-6691
bis(7)-tacrine
bis-(4-hydroxybenzyl)sulfide
cannabigerol
carnosine
CDP-choline
CGP-42112A
choline alfoscerate
cilostazol
CORM 3
creatine
curcumin
cyanidin cation
cycloheximide
dantrolene
Delta(9)-tetrahydrocannabinolic acid
dihydrolipoic acid
dimethyloxalylglycine
dizocilpine
dizocilpine maleate
ebselen
eliprodil
etazolate
ethoxyquin
ethylisopropylamiloride
fangchinoline
fasudil
fasudil hydrochloride
fasudil hydrochloride hydrate
felbamate
ferrostatin-1
flavalin A
flavalin B
fucoxanthin
galgravin
ginkgolide B
ginsenoside Rb1
ginsenoside Rb3
ginsenoside Rd
ginsenoside Re
ginsenoside Rg1
Glu-Asp-Arg
glycoursodeoxycholic acid
gossypin
GSK126
hinokiflavone
huperzine A
hydroxysafflor yellow A
ilomastat
indirubin-3'-monoxime
interiotherin C
jaspamide
juglanin A
ketone body
KU-55933
kynurenic acid
L-2-aminopentanoic acid
L-779976
L-817818
lanthionine ketimine
leucettine L41
liraglutide
lixisenatide
loganin
LY 379268
maysin
meldonium
melittin
memantine
memantine hydrochloride
menaquinone-4
methyl 3,4-dihydroxybenzoate
methylene blue
methylparaben
michigazone
midafotel
morin
N(5)-ethyl-L-glutamine
N,N'-bis(diphenylmethyl)ethane-1,2-diamine
N-[2-(4-phenoxybenzyl)benzimidazol-5-yl]methanesulfonamide
N-arachidonoyl-L-serine
N-benzylhexadecanamide
N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
N-tert-butyl(3,5,6-trimethylpyrazin-2-yl)methanimine N-oxide
N-{2-[(4-benzylpiperidin-1-yl)methyl]benzimidazol-5-yl}methanesulfonamide
necrosulfonamide
neriifolin
nerolidol
nicotinamide
NNC 55-0396 (free base)
NNC 55-0396 dihydrochloride
norgestrel
notoginsenoside R1
oleocanthal
oleuropein aglycone
p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe
paliperidone
paliperidone palmitate
palmitoyl ethanolamide
phenethyl caffeate
pinocembrin
PJ34
PJ34 hydrochloride
protectin D1
pterostilbene
pyrrolidine dithiocarbamate
rasagiline
RGFP966
rifampicin
rivastigmine
rivastigmine tartrate
Ro 25-6981
Ro 25-6981 maleate
rubimaillin
S-methyl-L-thiocitrulline
salvianolic acid B
salvigenin
SB 203580
SB 415286
semaglutide
SL-327
sodium phenylbutyrate
SU4312
sunitinib
syringin
taltirelin
tauroursodeoxycholic acid
TDZD-8
tenocyclidine
teprenone
tetrahydroxycurcumin
tetramethylpyrazine
tideglusib
trans-rhaponticin
triapine
trofinetide
Trolox
tropisetron
tropisetron hydrochloride
uridine triacetate
valproic acid
WIN 55212-2
xyloketal B
Z-DEVD-FMK
Show first 5 Terms
Phenotype
Phenotype resulting from neuroprotective agent
Phenotype where environments contain neuroprotective agent
Phenotype modified by environments containing neuroprotective agent
Human Disease / Model Data